Cargando…
Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study
OBJECTIVES: Possible immunomodulatory effect of amantadine in patients treated in intensive care unit (ICU), mostly among patients with brain injuries or vascular diseases was observed in several studies. The potential antiviral effect of amantadine against SARS-CoV-2 was discarded in clinical trial...
Autores principales: | Chober, Daniel, Czajkowski, Zenon, Aksak-Wąs, Bogusz, Dalewska-Kucharczyk, Katarzyna, Hołubczak, Katarzyna, Karasińska-Milchert, Sylwia, Jaremko, Mateusz, Skowron, Miłosz, Karasińska-Cieślak, Malwina, Parczewski, Miłosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490956/ https://www.ncbi.nlm.nih.gov/pubmed/36152957 http://dx.doi.org/10.1016/j.ijid.2022.09.026 |
Ejemplares similares
-
Septic Shock Induced by Vibrio Vulnificus in Northern Poland, a Case Report
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2021) -
Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022) -
Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland
por: Leszczyszyn-Pynka, Magdalena, et al.
Publicado: (2016) -
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022) -
Hepatotropic Properties of SARS-CoV-2—Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic
por: Wiśniewska, Hanna, et al.
Publicado: (2021)